Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2026-01-03 @ 6:26 AM
Study NCT ID:
NCT06584032
Status:
RECRUITING
Last Update Posted:
2025-01-07
First Post:
2024-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer
Sponsor:
Hutchmed
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-21
First Submit QC Date:
None
Study First Post Date:
2024-09-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-05
Last Update Post Date:
2025-01-07
Last Update Post Date Type:
ACTUAL